![]() |
Lung Cancer |
Free Subscription
1 AJR Am J Roentgenol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Lung Cancer is free of charge.
Prognostic Implications of the Volume Doubling Time of the Solid Component in
Lung Adenocarcinomas Manifesting as Part-Solid Lesions on Chest CT.
AJR Am J Roentgenol. 2025 Feb 12. doi: 10.2214/AJR.24.32470.
PubMed
Abstract available
Prevalence and Development of Cachexia Before and After Diagnosis of Non-small
Cell Lung Cancer.
Am J Clin Oncol. 2025 May 5. doi: 10.1097/COC.0000000000001211.
PubMed
Abstract available
Evaluation of turnaround times and performance of in-house ChromaCode
high-definition PCR compared to send-out next-generation sequencing in non-small
cell lung cancer.
Am J Clin Pathol. 2025 May 7:aqaf038. doi: 10.1093.
PubMed
Abstract available
Carcinogenic Industrial Air Emissions and Lung Cancer Risk in a Cohort of 440,000
Americans.
Am J Respir Crit Care Med. 2025.
PubMed
Abstract available
DNA Polymerase Delta 2 Activates Cell Cycle in Lung Adenocarcinoma, Leading to
High Malignancy and Poor Prognosis.
Ann Surg Oncol. 2025;32:4487-4496.
PubMed
Abstract available
Gait Speed as a Measure of Frailty and Outcomes After Lung Resection.
Ann Surg Oncol. 2025;32:4181-4188.
PubMed
Abstract available
Neoadjuvant Immunochemotherapy for Stage II-IIIB Non-Small Cell Lung Cancer with
Mutations Beyond EGFR 19del, L858R, and ALK rearrangement.
Ann Thorac Surg. 2025 May 6:S0003-4975(25)00378.
PubMed
Abstract available
Association Between Social Vulnerability Index and Time-to-Treatment in
Resectable Non-Small Cell Lung Cancer.
Ann Thorac Surg. 2025 May 6:S0003-4975(25)00380.
PubMed
Abstract available
Medicaid Expansion and Regionalization of Lung Cancer Surgery: A Double-Edged
Sword?
Ann Thorac Surg. 2025 May 2:S0003-4975(25)00374.
PubMed
Development and application of a whole transcriptome sequencing assay for the
detection of gene fusions in clinical cancer specimens.
BMC Cancer. 2025;25:842.
PubMed
Abstract available
Metabolic characteristics of benign and malignant pulmonary nodules and
establishment of invasive lung adenocarcinoma model by high-resolution mass
spectrometry.
BMC Cancer. 2025;25:844.
PubMed
Abstract available
FLT3LG modulates the infiltration of immune cells and enhances the efficacy of
anti-PD-1 therapy in lung adenocarcinoma.
BMC Cancer. 2025;25:831.
PubMed
Abstract available
Whole-body CT scanning radiation improves the immune microenvironment of tumor
tissues to enhance the antitumor effect of ICI.
BMC Cancer. 2025;25:824.
PubMed
Abstract available
Cemiplimab monotherapy as first-line treatment of patients with brain metastases
from advanced non-small cell lung cancer with programmed cell death-ligand 1 >/=50.
Cancer. 2025;131:e35864.
PubMed
Abstract available
Immunotherapy for resectable lung cancer.
Cancer. 2025;131:e35849.
PubMed
Abstract available
The Integrated Stress Response Pathway Coordinates Translational Control of
Multiple Immune Checkpoints in Lung Cancer.
Cancer Res. 2025 May 6. doi: 10.1158/0008-5472.CAN-24-3844.
PubMed
Abstract available
MACC1 is a potential prognostic biomarker for cancer immunotherapy in lung
adenocarcinoma.
Carcinogenesis. 2025;46:bgaf015.
PubMed
Abstract available
Prognostic Implications of Lymph Node Status in Non-Small-Cell Lung Cancer
Patients Before and After Neoadjuvant Chemoimmunotherapy: A Multicenter
Retrospective Study.
Clin Lung Cancer. 2025 Apr 8:S1525-7304(25)00062.
PubMed
Abstract available
Outcomes and Toxicity following 3 or More Definitive Courses of Thoracic
Radiation Therapy for Non-Small Cell Lung Cancer.
Clin Lung Cancer. 2025 Apr 10:S1525-7304(25)00060.
PubMed
Abstract available
Primary Pulmonary MALT Lymphoma on 18F-FDG and 68Ga-FAPI PET/CT.
Clin Nucl Med. 2025 Jan 20. doi: 10.1097/RLU.0000000000005687.
PubMed
Abstract available
Is histological confirmation necessary to avoid futile resections? Comparative of
4 university hospitals.
Eur J Cardiothorac Surg. 2024;65:ezae136.
PubMed
Abstract available
Lymph node sampling and survival in non-small cell lung cancer: A 10-year Danish
cohort study.
Eur J Cardiothorac Surg. 2025 May 8:ezaf158. doi: 10.1093.
PubMed
Abstract available
Erratum: Every Patient Is Unique and Deserves the Best: The Present and Future
Treatment Landscape of Uncommon Epidermal Growth Factor Receptor Mutations in
Non-Small Cell Lung Cancer.
J Clin Oncol. 2025 May 8:JCO2500997. doi: 10.1200/JCO-25-00997.
PubMed
Association of radiation-induced normal tissue toxicity with a high genetic risk
for rheumatoid arthritis.
J Natl Cancer Inst. 2025;117:1018-1026.
PubMed
Abstract available
Early Compliance with Lung Cancer Lymph Node Standard 5.8: An Analysis of 2022
and 2023 Commission on Cancer Site Reviews.
J Thorac Cardiovasc Surg. 2025 Apr 29:S0022-5223(25)00340.
PubMed
Abstract available
Provider and Procedural Factors Associated with Guideline-Concordant Lymph Node
Sampling in Lung Cancer Resection.
J Thorac Cardiovasc Surg. 2025 Apr 17:S0022-5223(25)00304.
PubMed
Abstract available
Lung Cancer Recurrence after Neoadjuvant Immunotherapy.
J Thorac Cardiovasc Surg. 2025 Apr 20:S0022-5223(25)00328.
PubMed
Abstract available
Overall Survival in EGFR-mutant Advanced Non-Small Cell Lung Cancer Treated with
First-line Osimertinib: A Cohort Study Integrating Clinical and Biomarker Data in
the United States.
J Thorac Oncol. 2025 May 2:S1556-0864(25)00699.
PubMed
Abstract available
Harm-Benefit Balance of Immune Checkpoint Inhibitors in Non-Small Cell Lung
Cancer.
JAMA Oncol. 2025 May 8. doi: 10.1001/jamaoncol.2025.0985.
PubMed
Abstract available
Epidemiology and clinical course of large cell neuroendocrine carcinoma of the
lung: The Japanese lung cancer registry study.
Lung Cancer. 2025;204:108557.
PubMed
Abstract available
Artificial intelligence in predicting EGFR mutations from whole slide images in
lung Cancer: A systematic review and Meta-Analysis.
Lung Cancer. 2025;204:108577.
PubMed
Abstract available
Cancer-associated fibroblasts promote EGFR-TKI resistance via the
CTHRC1/glycolysis/H3K18la positive feedback loop.
Oncogene. 2025;44:1400-1414.
PubMed
Abstract available
Real-world treatment and outcomes for EGFR WT advanced/metastatic non-squamous
non-small cell lung cancer: pooled analysis from project LUMINATE-101.
Oncologist. 2025;30:oyaf029.
PubMed
Abstract available
A rising tide lifts all boats in the personalized cancer care continuum for
mNSCLC: bridging inequities in NGS fosters equity in targeted treatment.
Oncologist. 2025;30:oyaf067.
PubMed
Abstract available
Revealing cancer driver genes through integrative transcriptomic and epigenomic
analyses with Moonlight.
PLoS Comput Biol. 2025;21:e1012999.
PubMed
Abstract available
Exploring the impact of surgical treatment for lung cancer in patients with
Airway Obstruction from a Lung Cancer Screening Program.
PLoS One. 2025;20:e0320704.
PubMed
Abstract available
Finding patterns in lung cancer protein sequences for drug repurposing.
PLoS One. 2025;20:e0322546.
PubMed
Abstract available
A comparative analysis of the burden, trends and inequalities of tracheal,
bronchus, and lung cancer in India from 2000 to 2021: A systematic analysis for
the Global Burden of Disease study 2021.
PLoS One. 2025;20:e0322646.
PubMed
Abstract available
Gene expression-based identification of prognostic markers in lung
adenocarcinoma.
PLoS One. 2025;20:e0310232.
PubMed
Abstract available
The oncoprotein SET promotes serine-derived one-carbon metabolism by regulating
SHMT2 enzymatic activity.
Proc Natl Acad Sci U S A. 2025;122:e2412854122.
PubMed
Abstract available
High tumor mutation burden mitigates the negative impact of chemotherapy history
on immune checkpoint blockade therapy.
Semin Oncol. 2025;52:152334.
PubMed
Abstract available
Thank you for your interest in scientific medicine.